Background
People with disabilities (PWD) are at higher risk of experiencing substance use (SU) disorders than those without a disability. While treatment for SU reduces mortality and morbidity, currently there are no national-level studies comparing US adults with and without disabilities in terms of SU treatment receipt, perceived need, and barriers.
Objective
To examine differences between US adults with and without disabilities in terms of SU treatment receipt, perceived need for treatment, and barriers to receiving treatment.
Methods
This cross-sectional study examined National Survey on Drug Use and Health (NSDUH) 2022–2023 data (n = 89,167 adults) on self-reported disability and past-year substance use disorder (SUD), SU treatment, unmet treatment need, and treatment barriers. Analyses included weighted prevalence estimates, chi-squared tests (corrected for the survey design), and binomial logistic regression.
Results
An estimated 10.0 % of adults with a disability, versus 3.9 % without a disability, reported receiving past-year SU treatment. For adults with a past-year SUD who did not receive treatment, reporting a disability was associated with 70 % higher odds (Adjusted Odds Ratio [AOR] 1.70; 95 % Confidence Interval [CI], 1.27–2.28) of “unmet need” for SU treatment (after adjusting for demographics). Among adults who reported an “unmet need” for SU treatment, barriers related to cost and stigma were reported more frequently in those with, compared to those without, a disability.
Conclusions
Findings highlight elevated SU treatment need and barriers for PWD. Understanding the intersection of disability with the cascade of care, from screening to diagnosis and treatment of SU, is critical in improving health outcomes.
扫码关注我们
求助内容:
应助结果提醒方式:
